China: Copyright

Subscribe
Intellectual property law and copyright law thought leadership, articles, podcasts, videos and webinars from expert sources across the legal world. Explore insights covering topics such as licensing and syndication, patent law, trade secrets and trademark law.
Article
News & Cases From China: June 2026
China's National People's Congress has released a comprehensively revised Trademark Law featuring 87 articles across nine chapters, introducing motion signs as registrable marks, strengthening penalties for bad-faith filings, and expanding protection for well-known trademarks. How will these reforms reshape trademark registration practices and enforcement strategies for businesses operating in China's evolving intellectual property landscape?
China IP
R
Rouse
Article
谁之“非遗”?何种法权益?——非物质文化遗产的知识产权保护运行机制
“南京绒花”是南京具有地方特色的代表性传统手工艺品,因其制作精美,又有“荣华”的吉祥寓意,常被妇女戴于发髻以做装饰,于2006年被列入江苏省非物质文化遗产名录。原告赵树宪是江苏省非物质文化遗产绒花制作技艺代表性传承人,其代表作品有“福寿三多”等绒花作品,为保证其创
China IP
AB
AnJie Broad Law Firm
Article
China’s First Copyright Dispute Over An AI-Generated Short Drama Clarifies The Legal Boundaries Of Creation And Use
China's Huangpu District People's Court has issued a landmark ruling in the country's first criminal case involving AI-generated short drama copyright infringement. The case examines whether AI-created content can receive copyright protection and establishes legal boundaries for creators using artificial intelligence tools. Two defendants faced prosecution for unauthorized recording and distribution of over 1,700 AI-generated short dramas, raising critical questions about originality, authorship, and crimin
China IP
R
Rouse
Article
AFD China Newsletter - June 2026
China's intellectual property landscape is undergoing significant transformation with new protections for clinical trial data, enhanced copyright enforcement in AI-generated content, and landmark Supreme Court rulings on patent jurisdiction and inventiveness. The newsletter examines how regulatory changes and judicial decisions are reshaping IP rights for pharmaceutical companies, technology platforms, and patent holders navigating complex infringement disputes.
China IP
AC
AFD China
See more